people in Ireland live longer, healthier and more active lives, in part, due to
medical progress and pharmaceutical research and development.
timely use of innovative medicines has:
- Helped to improve life
expectancy in Ireland by over a third in the last seventy years, from 57
in 1925 to 81 today.
- Enabled Irish hospitals to
treat patients on a day case basis, from 390,000 cases in 2002 to an
estimated 900,000 in 2012.
- Helped thousands of Irish
patients with Parkinson’s, Alzheimer’s, ulcers, cancer, diabetes and
mental illness to lead better and more normal lives, easing the burden on
care-givers and delaying or avoiding costly long-term nursing care.
- Contributed to reducing the
number of deaths from heart disease and stroke by nearly a half - the
number one cause of death in Ireland.
- Reduced the rate of death
for heart attack patients in hospitals by nearly 45% and the rate of
subsequent heart attacks in a period of six months following initial
treatment by 60%.
- Ensured that previously
leading causes of death such as pneumonia, TB, polio and measles can now
be successfully treated globally.
only is the pharmaceutical industry critical to the health of the nation, it
plays a critical and substantial role in the Irish economy.
pharmaceutical industry in Ireland:
- Currently generates over 50
percent of the country’s exports contributing to making Ireland the
largest net exporter of medicines in the EU.
- Maintains substantial operations
belonging to 9 of the top 10 companies in the world.
- Manufactures 5 of the
world's top 20 medicines.
- Directly employs over 24,500
half of which are third level graduates.
- Employs another 24,500
people in the provision services to the sector.
- Between 2011 and 2013 over
€1.7 billion invested in the sector which has led to the creation of an
additional 1,500 jobs.